TC
BIIB icon

Telemus Capital’s Biogen BIIB Stock Holding History

Telemus Capital’s Portfolio BIIB Stock Details BIIB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-2,267
Closed -$785K – 357
2021
Q2 		$785K Sell
2,267
-241
-10% -$73K 0.06% 203
2021
Q1 		$697K Buy
2,508
+223
+10% +$60.1K 0.05% 239
2020
Q4 		$560K Buy
2,285
+701
+44% +$181K 0.04% 244
2020
Q3 		$444K Buy
+1,584
New +$442K 0.03% 324
2019
Q2 		– Sell
-974
Closed -$230K – 375
2019
Q1 		$230K Buy
+974
New +$307K 0.02% 381
2018
Q4 		– Sell
-680
Closed -$240K – 424
2018
Q3 		$240K Buy
+680
New +$234K 0.02% 397
2018
Q1 		– Sell
-230
Closed -$73K – 422
2017
Q4 		$73K Buy
+230
New +$73.8K 0.01% 419

Other funds holding BIIB

Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Telemus Capital's BIIB Position: Q3 2021 in Review

Telemus Capital sold out of Biogen (BIIB) in Q3 2021, closing a stake of 2,267 shares — an estimated $785K sold.

Telemus Capital first reported a position in BIIB in Q4 2017 and held it in 7 quarters. The position peaked at $785K in Q2 2021. 1,041 funds tracked by Wall St. Rank hold BIIB as of Q3 2021.

  • Telemus Capital reported no remaining Biogen position as of Q3 2021 after selling out during the quarter.
  • Telemus Capital sold 2,267 Biogen shares in Q3 2021, an estimated $785K.
  • Telemus Capital first reported a position in Biogen in Q4 2017 and held it in 7 quarters.
  • Telemus Capital's Biogen position peaked at $785K in Q2 2021.
  • 1,041 funds tracked by Wall St. Rank held Biogen as of Q3 2021.

Based on Telemus Capital's 13F filing for Q3 2021, filed 27 Oct 2021.